Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer
Titel:
Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer
Auteur:
Twelves, C. Chmielowska, E. Havel, L. Popat, S. Swieboda-Sadlej, A. Sawrycki, P. Bycott, P. Ingrosso, A. Kim, S. Williams, J.A. Chen, C. Olszanski, A.J. de Besi, P. Schiller, J.H.